HUP0401294A3 - Use of acetyl l-carnitine for the preparation of a pharmaceutical composition for the preventive therapy for pain - Google Patents
Use of acetyl l-carnitine for the preparation of a pharmaceutical composition for the preventive therapy for painInfo
- Publication number
- HUP0401294A3 HUP0401294A3 HU0401294A HUP0401294A HUP0401294A3 HU P0401294 A3 HUP0401294 A3 HU P0401294A3 HU 0401294 A HU0401294 A HU 0401294A HU P0401294 A HUP0401294 A HU P0401294A HU P0401294 A3 HUP0401294 A3 HU P0401294A3
- Authority
- HU
- Hungary
- Prior art keywords
- carnitine
- acetyl
- pain
- preparation
- pharmaceutical composition
- Prior art date
Links
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000009117 preventive therapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001RM000293A ITRM20010293A1 (it) | 2001-05-29 | 2001-05-29 | Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore. |
| PCT/IT2002/000336 WO2002096409A1 (en) | 2001-05-29 | 2002-05-24 | Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0401294A2 HUP0401294A2 (hu) | 2004-12-28 |
| HUP0401294A3 true HUP0401294A3 (en) | 2008-04-28 |
Family
ID=11455557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401294A HUP0401294A3 (en) | 2001-05-29 | 2002-05-24 | Use of acetyl l-carnitine for the preparation of a pharmaceutical composition for the preventive therapy for pain |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20040152781A1 (enExample) |
| EP (1) | EP1399141B1 (enExample) |
| JP (1) | JP4287660B2 (enExample) |
| KR (1) | KR100873748B1 (enExample) |
| AT (1) | ATE374021T1 (enExample) |
| CA (1) | CA2448242C (enExample) |
| CY (1) | CY1107037T1 (enExample) |
| CZ (1) | CZ20033220A3 (enExample) |
| DE (1) | DE60222662T2 (enExample) |
| DK (1) | DK1399141T3 (enExample) |
| ES (1) | ES2290292T3 (enExample) |
| HU (1) | HUP0401294A3 (enExample) |
| IT (1) | ITRM20010293A1 (enExample) |
| MX (1) | MXPA03010919A (enExample) |
| PL (1) | PL367616A1 (enExample) |
| PT (1) | PT1399141E (enExample) |
| SK (1) | SK287559B6 (enExample) |
| WO (1) | WO2002096409A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20040606A1 (it) | 2004-12-13 | 2005-03-13 | Sigma Tau Ind Farmaceuti | Uso della acetil l-carnitina per il trattamento della sindrome fibromialgica. |
| JP5685362B2 (ja) * | 2005-04-26 | 2015-03-18 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ | 有痛性末梢糖尿病性神経障害の予防のためのアセチルｌ−カルニチン |
| IT202200022437A1 (it) | 2022-11-02 | 2024-05-02 | Chiesi Italia S P A | Composizione farmaceutica comprendente l-acetilcarnitina e beta-cariofillene |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3463261D1 (en) * | 1983-12-28 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
| IT1196564B (it) * | 1986-08-04 | 1988-11-16 | Sigma Tau Ind Farmaceuti | Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche |
| IT1277147B1 (it) * | 1995-01-20 | 1997-11-04 | Sigma Tau Ind Farmaceuti | Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi. |
-
2001
- 2001-05-29 IT IT2001RM000293A patent/ITRM20010293A1/it unknown
-
2002
- 2002-05-24 US US10/478,379 patent/US20040152781A1/en not_active Abandoned
- 2002-05-24 ES ES02728055T patent/ES2290292T3/es not_active Expired - Lifetime
- 2002-05-24 KR KR1020037015574A patent/KR100873748B1/ko not_active Expired - Fee Related
- 2002-05-24 DK DK02728055T patent/DK1399141T3/da active
- 2002-05-24 WO PCT/IT2002/000336 patent/WO2002096409A1/en not_active Ceased
- 2002-05-24 SK SK1584-2003A patent/SK287559B6/sk not_active IP Right Cessation
- 2002-05-24 DE DE60222662T patent/DE60222662T2/de not_active Expired - Lifetime
- 2002-05-24 AT AT02728055T patent/ATE374021T1/de not_active IP Right Cessation
- 2002-05-24 PL PL02367616A patent/PL367616A1/xx not_active IP Right Cessation
- 2002-05-24 CZ CZ20033220A patent/CZ20033220A3/cs unknown
- 2002-05-24 MX MXPA03010919A patent/MXPA03010919A/es active IP Right Grant
- 2002-05-24 EP EP02728055A patent/EP1399141B1/en not_active Expired - Lifetime
- 2002-05-24 HU HU0401294A patent/HUP0401294A3/hu unknown
- 2002-05-24 JP JP2002592919A patent/JP4287660B2/ja not_active Expired - Fee Related
- 2002-05-24 CA CA2448242A patent/CA2448242C/en not_active Expired - Fee Related
- 2002-05-24 PT PT02728055T patent/PT1399141E/pt unknown
-
2007
- 2007-11-28 CY CY20071101520T patent/CY1107037T1/el unknown
-
2008
- 2008-09-26 US US12/232,945 patent/US20090062388A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090062388A1 (en) | 2009-03-05 |
| KR100873748B1 (ko) | 2008-12-12 |
| JP2004532865A (ja) | 2004-10-28 |
| CA2448242C (en) | 2011-01-11 |
| SK287559B6 (sk) | 2011-02-04 |
| JP4287660B2 (ja) | 2009-07-01 |
| WO2002096409A1 (en) | 2002-12-05 |
| SK15842003A3 (sk) | 2004-06-08 |
| KR20040003030A (ko) | 2004-01-07 |
| CY1107037T1 (el) | 2012-09-26 |
| EP1399141B1 (en) | 2007-09-26 |
| ATE374021T1 (de) | 2007-10-15 |
| ITRM20010293A0 (it) | 2001-05-29 |
| CA2448242A1 (en) | 2002-12-05 |
| PT1399141E (pt) | 2007-11-16 |
| US20040152781A1 (en) | 2004-08-05 |
| ITRM20010293A1 (it) | 2002-11-29 |
| ES2290292T3 (es) | 2008-02-16 |
| DK1399141T3 (da) | 2008-01-02 |
| DE60222662D1 (de) | 2007-11-08 |
| CZ20033220A3 (en) | 2004-06-16 |
| EP1399141A1 (en) | 2004-03-24 |
| PL367616A1 (en) | 2005-03-07 |
| MXPA03010919A (es) | 2004-02-27 |
| DE60222662T2 (de) | 2008-06-26 |
| HUP0401294A2 (hu) | 2004-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0202319A3 (en) | Use of mek inhibitors for the preparation of pharmaceutical compositions treating chronic pain | |
| HUP0501089A2 (en) | Therapeutic isoquinoline compounds and pharmaceutical compositions coutaining them | |
| HU0103558D0 (en) | Pharmaceutical composition for the treatment of stroke and traumatic brain insury | |
| HUP0400529A3 (en) | Use of chlorpromazine and pentamidine for preparation of pharmaceutical compositions for the treatment of neoplastic disorders | |
| IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
| PL356358A1 (en) | Solid dosage form of someticone for oral administration | |
| HRP20030873A2 (en) | Pharmaceutical dosage form of amorphous nelfinavirmesylatoe having such element | |
| IL219396A0 (en) | Compounds for the treatment of metabolic disorders and pharmaceutical compositions containing same | |
| SI1390023T1 (sl) | Farmacevtske soli spojin 1-fenil-3-dimetilamino-propana | |
| HUP0202719A3 (en) | Pharmaceutical compositions for the treatment of female sexual dysfunctions | |
| GB0117618D0 (en) | Pharmaceutical dosage form | |
| HUP0302726A3 (en) | Methods of administering pharmaceutical composition containing epothilone analogs for the treatment of cancer and of preparation the same | |
| HUP0201834A3 (en) | Use of thyromimetic compounds for the manufacture of a pharmaceutical composition for the treatment of hair loss and such compositions | |
| IL164896A (en) | Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors | |
| GB0117619D0 (en) | Pharmaceutical dosage form | |
| IL147826A0 (en) | Multi-component pharmaceutical dosage form | |
| HUP0500638A3 (en) | Flashmelt oral dosage formulation | |
| IL153831A (en) | Pharmaceutical composition for therapy of neurodegenerative disease of the brain | |
| AU2002338303A1 (en) | Therapeutic compositions for the treatment of a respiratory tract disease | |
| HUP0102159A3 (en) | Pharmaceutical composition for the treatment of rumen acidosis | |
| HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
| EP1372616A4 (en) | STABLE PHARMACEUTICAL COMPOSITION BASED ON PRAVASTATIN | |
| IL147496A0 (en) | Preparation of a therapeutic composition | |
| HUP0202314A3 (en) | Use of acetyl l-carnitine and propionyl l-carnitine for producing a pharmaceutical composition for the prevention and treatment of kidney dysfunctions and diseases | |
| HUP0200253A3 (en) | Pharmaceutical compositions for combination therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |